Int J Biol Markers 2017; 32(4): e447-e453 DOI: /ijbm Meta-analysis of prognostic role of Ki-67 labeling index in gastric carcinoma
|
|
- Clyde Scott
- 6 years ago
- Views:
Transcription
1 IJBM eissn Int J Biol Markers 2017; 32(4): e447-e453 DOI: /ijbm ORIGINAL RESEARCH ARTICLE Meta-analysis of prognostic role of Ki-67 labeling index in gastric carcinoma Jung-Soo Pyo 1,2, Nae Yu Kim 2,3 1 Department of Pathology, Eulji University Hospital, Eulji University School of Medicine, Daejeon - Republic of Korea 2 Study Group for Meta-Analysis, Eulji University Hospital, Eulji University School of Medicine, Daejeon - Republic of Korea 3 Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine, Daejeon - Republic of Korea ABSTRACT Background: This meta-analysis aimed to elucidate the prognostic role of the Ki-67 labeling index (LI) in gastric cancer (GC). Methods: The current study included 3,615 GC patients in 20 eligible studies, and evaluated the prognostic role of Ki-67 LI in GC. Subgroup analysis was conducted based on depth of invasion and cutoff value for high Ki-67 LI. Results: A high Ki-67 LI correlated significantly with worse survival (hazard ratio [HR] = 1.214, 95% confidence interval [CI], ). However, there was no significant correlation between high Ki-67 LI and worse survival in advanced GC (HR = 1.252, 95% CI, ). The subgroup with cutoff value 25% showed a significant correlation with worse survival, but this was not seen in the subgroup with cutoff >25% (HR = 1.433, 95% CI, vs. HR = 1.005, 95% CI, ). In addition, in the 10% < Ki-67 LI 20% range, there was a significant correlation between high Ki-67 LI and worse overall survival (HR = 1.931, 95% CI, ). Conclusions: A high Ki-67 LI correlated significantly with a worse prognosis in GC patients. Further cumulative studies for the optimal cutoff value for high Ki-67 LI are needed before application in clinical practice. Keywords: Gastric carcinoma, Ki-67 labeling index, Meta-analysis, Prognostic role Introduction Gastric carcinoma (GC) is a biologically and genetically heterogeneous tumor and one of the most common malignant tumors worldwide (1). The incidence of GC varies markedly with geography. In Asia, Eastern Europe, Chile and Costa Rica, the incidence is significantly higher than in North America, Northern Europe, Africa and Southeast Asia (1, 2). In regions with successful endoscopic screening programs, the incidence of early GC (EGC) is higher than in other regions. The American Joint Committee on Cancer tumor-nodemetastasis (TNM) classification is an important prognostic Received: February 26, 2017 Accepted: April 27, 2017 Published online: May 27, 2017 Corresponding author: Prof. Nae Yu Kim Department of Internal Medicine Eulji University Hospital Eulji University School of Medicine 95 Dunsanseo-ro, Seo-gu Daejeon, Republic of Korea naeyu46@eulji.ac.kr factor (3), but GCs of the same TNM stage may show variable prognoses. Many studies have reported several biological and molecular biomarkers, such as HER2 (4), p53 (5), FOXO1A (6), Bcl-2 (7), E-cadherin (8), cyclooxygenase 2 (9, 10) and VEGFR (11) for predicting GC prognosis. However, for the prediction of prognosis in GC, the use of these histopathological and biological markers has not been fully elucidated, and these candidates have not been widely used in daily clinical practice. Therefore, studies of novel prognostic markers or systematic reviews and meta-analyses for previously discovered markers are needed. The Ki-67 protein, a nuclear nonhistone protein, is differentially expressed according to the cell cycle and could be expressed in the nuclei of cells in the G1, S, G2 and M phases of proliferating cells (12). However, the Ki-67 protein is not expressed in quiescent or resting cells in the G0 phase (13). Therefore, cells expressing the Ki-67 protein are considered to be proliferating cells. Although the Ki-67 labeling index (LI) might be a useful prognostic marker in various malignancies (14), its prognostic role is controversial in GC. In the present meta-analysis, we investigated the correlation between the Ki-67 LI and overall survival in 3,615 patients using data from 20 eligible studies (7, 9, 10, 15-31). Moreover, the correlation between pathological stages and a high Ki-67 LI was elucidated from all available studies.
2 e448 Prognostic role of Ki-67 Materials and methods Search of published studies and selection criteria Relevant articles were obtained by searching the PubMed and MEDLINE databases up to January 31, Searches were performed using the following key words: gastric carcinoma, Ki-67, MIB-1 or survival. The title and abstract of all searched articles were screened for exclusion. Review articles were also screened to find additional eligible studies. Articles were included if the study was performed in human GC patients and if there was information about the correlation between high Ki-67 LI and survival rate. Articles were excluded if they were case reports or nonoriginal articles, or if the article was not written in English or Korean. Among the eligible studies, Tokuyasu et al (26) demonstrated separate information according to intestinal and diffuse type; therefore, we counted it as 2 studies in the data extraction process (Tab. I) after the study search (Fig. 1). Data extraction Data from all eligible studies were extracted by 2 authors. The included data were extracted from each of the eligible studies (7, 9, 10, 15-31): the first author s name, year of publication, study location, antibody manufacturer, dilution ratio of Ki-67 or MIB-1 antibody, cutoff value for high Ki-67 LI, number of patients analyzed, and pathological tumor-node-metastasis (ptnm) stage. For quantitative aggregation of survival results, the correlation between high Ki-67 LI and overall or disease-free survival rate was analyzed according to the hazard ratio (HR) using 1 of 3 methods. In studies not quoting the HR or its confidence interval (CI), these variables were calculated from the presented data using the HR point estimate, log-rank statistic or its p value, and the O-E statistic (difference between the number of observed and expected events) or its variance. If those data were unavailable, HR was estimated using the total number of events, number of patients at risk in each group, and the logrank statistic or its p value. Finally, if the only useful data were in the form of graphical representations of survival distributions, TABLE I - Main characteristics of the eligible studies First author, year (ref.) Location Cutoff value (%) No. Ki-67 LI EGC AGC Tumor stage High Low I II III IV Böger, 2016 (15) Germany Chen, 2008 (16) China Czyzewska, 2009 (17) Poland He, 2013 (18) China Ichinoe, 2011 (19) Japan Joo, 2006 (9) Korea Lee, 2010 (20) Korea Lee, 2005 (21) Korea Liu, 2001 (22) Japan Mrena, 2010 (10) Finland Müller, 1996 (23) Germany Shomori, 2010 (24) Japan Sun, 2014 (25) China Tokuyasu, 2008 (26) Japan Intestinal type Diffuse type Tsamandas, 2009 (7) Greece Tzanakis, 2009 (27) Greece Victorzon, 1997 (28) Finland Wen, 2011 (29) China Wu, 2014 (30) China Xiao, 2013 (31) Japan AGC = advanced gastric carcinoma; EGC = early gastric carcinoma; LI = labeling index; No. = number of patients.
3 Pyo and Kim e449 Fig. 1 - Flow chart for study search and selection. survival rates were extracted at specified times to reconstruct the HR estimate and its variance under the assumption that patients were censored at a constant rate during the time intervals (32). The published survival curves were read independently by 2 authors to reduce reading variability. Data associated with survival were extracted after a 60-month follow-up period. The HRs were then combined into an overall HR using Peto s method (33). Statistical analysis To perform the meta-analysis, all data were analyzed by the Comprehensive Meta-Analysis software package (Biostat, Englewood, NJ, USA). We investigated the correlation between high Ki-67 LI and survival rate in GC. To obtain the optimal cutoff value for high Ki-67 LI, subgroup analysis was conducted. In addition, the rates of high Ki-67 LI according to depth of invasion, lymph node metastasis and TNM stage were investigated. Heterogeneity between studies was checked by the Q and I 2 statistics and demonstrated p values. Meta-regression test and sensitivity analysis were conducted to assess the heterogeneity of eligible studies and the impact of each study on the combined effect, respectively. In the current meta-analysis, because eligible studies used various detection methods and populations, the application of a random-effects model rather than a fixed-effects model was more suitable. For assessment of publication bias, Begg s funnel plot and Egger s test were performed. If significant publication bias was found, fail-safe N and trim-fill tests were performed to confirm the degree of publication bias. The results were considered statistically significant when p was <0.05. Results Selection and characteristics of studies The current study discovered 203 reports from the database search. Among these reports, 93 were excluded because of insufficient or no information. In addition, 73 reports were excluded as they focused on other diseases, and 17 because they were studies that used animals or cell lines (n = 7), were non-english or non-korean (n = 7) or were duplicated (n = 1) or nonoriginal (n = 2) reports. Finally, 20 eligible studies were included in the current meta-analysis (Fig. 1; Tab. I). This study included data about 3,615 GC patients. In addition, the cutoff values for the Ki-67 LI varied between 1% and 69.0% (Tab. I). Meta-analysis A high Ki-67 LI was significantly correlated with worse overall survival (HR = 1.214, 95% CI, ; Fig. 2A). Eligible studies showed significant heterogeneity (I 2 = 94.4%, p<0.001). Sensitivity analysis was also performed and included studies which had no effect on the pooled HR. The range of HRs was in the sensitivity analysis. There was no significant publication bias revealed by Egger s test (p = 0.986) or Begg s funnel plot. In the advanced GC (AGC) subgroup, there was no significant correlation between a high Ki-67 LI and worse overall survival (HR = 1.252, 95% CI, ; Fig. 2B). Next, we performed subgroup analyses to obtain the optimal cutoff value for high Ki-67 LI. Subgroups with cutoff values of 25% and those with lower than 25% showed significantly poorer survival rates (HR = 1.433, 95% CI, )
4 e450 Prognostic role of Ki-67 Fig. 2 - Forest plot diagram for the correlation between high Ki-67 labeling index and overall survival in overall cases (A) and advanced gastric carcinomas (B). than the subgroup with cutoff values of higher than 25%, which showed no significant difference between high and low Ki-67 LI patients (HR = 1.005, 95% CI, ). In addition, in various cutoff value ranges, the prognostic roles of high Ki-67 were analyzed. In the range 10% < Ki-67 LI 20%, there was a significant correlation between high Ki-67 LI and worse overall survival (HR = 1.931, 95% CI, ). However, in other cutoff value ranges, there was no significant correlation (Fig. 3). The rates of high Ki-67 LI were investigated according to depth of invasion, lymph node metastasis and ptnm stage (Tab. II). The rates of high Ki-67 LI were (95% CI, ) and (95% CI, ) in T1 and T2-4 subgroups, respectively. There was no significant difference of the rate of high Ki-67 LI between GC patients with or without nodal disease (0.586, 95% CI, vs , 95% CI, ) or between those with higher and lower TNM stages (0.602, 95% CI, vs , 95% CI, ). Discussion The Ki-67 LI is a useful prognostic factor in various malignancies, such as neuroendocrine tumors and breast carcinomas (1, 14). In gastrointestinal stromal tumors, the Ki-67 LI has been reported to be an important prognostic factor (34). However, the prognostic role of the Ki-67 LI remains controversial in GC, despite an increase in the number of published reports. To the best of our knowledge, the present study is the first meta-analysis of published studies evaluating the prognostic role of the Ki-67 LI in GC. The current meta-analysis showed a significant correlation between a high Ki-67 LI and worse overall survival. Eligible studies used mean, median, optimal cutoff value or arbitrary values for the Ki-67 LI. We performed subgroup analysis to determine the optimal Ki-67 LI cutoff value for the prediction of prognosis. A high Ki-67 LI was significantly correlated with a worse prognosis in studies with a cutoff value of 25% and lower (HR = 1.433, 95% CI, ),
5 Pyo and Kim e451 Fig. 3 - Forest plot diagram for subgroup analysis based on Ki-67 labeling index (LI) cutoff value: hazard ratios with 95% confidence intervals. TABLE II - Meta-analysis of higher Ki-67 labeling index and clinicopathological stages of gastric carcinoma Stratified analysis Number of studies Fixed effects (95% CI) Heterogeneity, p value Random effects (95% CI) Egger s test, p value Depth of invasion T (0.433, 0.595) (0.304, 0.711) Cutoff of LI 25% (0.426, 0.596) (0.426, 0.596) - Cutoff of LI > 25% (0.287, 0.781) (0.017, 0.953) - T (0.459, 0.551) < (0.260, 0.767) Cutoff of LI 25% (0.444, 0.539) (0.444, 0.539) - Cutoff of LI > 25% (0.492, 0.778) < (0.006, 0.995) - Lymph node metastasis Present (0.417, 0.501) < (0.430, 0.726) Cutoff of LI 25% (0.403, 0.505) < (0.392, 0.912) Cutoff of LI > 25% (0.394, 0.543) (0.394, 0.543) - Absent (0.449, 0.564) < (0.364, 0.709) Cutoff of LI 25% (0.375, 0.533) < (0.192, 0.840) Cutoff of LI > 25% (0.481, 0.645) (0.481, 0.645) - ptnm stage I II (0.491, 0.618) (0.454, 0.733) Cutoff of LI 25% (0.410, 0.565) (0.410, 0.565) - Cutoff of LI > 25% (0.584, 0.777) (0.476, 0.889) - III IV (0.414, 0.499) < (0.423, 0.755) Cutoff of LI 25% (0.383, 0.481) (0.338, 0.592) - Cutoff of LI > 25% (0.440, 0.602) < (0.138, 0.991) - CI = confidence interval; LI = labeling index; ptnm stage = pathological tumor-node-metastasis stage. but not in studies with a cutoff value higher than 25% (HR = 1.005, 95% CI, ). A high Ki-67 LI was significantly associated with a poor prognosis in studies with a cutoff value of 10% and lower than 10% (HR = 1.343, 95% CI, ). In addition, in the range of 10% < Ki-67 LI 20%, there was a significant correlation between a high Ki-67 LI and worse overall survival (HR = 1.931, 95% CI, ). These results suggest that the optimal predictive cutoff value may be a certain value within a range for Ki-67 LI > 10% and 25%. Further cumulative studies for validation of optimal cutoff value and method standardization for evaluating the Ki-67 LI are needed for application in daily clinical practice.
6 e452 Prognostic role of Ki-67 In the current meta-analysis, the pooled HR of overall survival was 1.214, and this was lower than for other malignant tumors (34, 35). In addition, in gastrointestinal stromal tumors, the pooled HR of overall survival was (95% CI, ) (36). As described in the Results section, a significant heterogeneity was identified between eligible studies (I 2 = 94.4%, p<0.001). In addition, eligible studies have reported varying results for the correlation between a high Ki-67 LI and prognosis. These varying results could be caused by several factors, such as dilution ratios, antibody manufacturers, immunohistochemical staining methods and evaluation protocols for Ki-67 LI. Among the 20 eligible studies, 1 study, by Lee et al, showed that a high Ki-67 LI was negatively correlated with a lower survival rate (20). It posited that early carcinomas with higher proliferative ability may show a high Ki-67 LI, and may be correlated with a better prognosis. However, in the sensitivity analysis, this single report had no noteworthy influence on the pooled HR (from HR = to HR = 1.285). In addition, we failed to find a significant difference in method, evaluation system or composition of patients between the report by Lee et al (20) and other eligible reports. Therefore, a detailed analysis is required to obtain the information for the prognostic role of high Ki-67 LI, and meta-analysis could be a suitable method. High-incidence regions of GC include Eastern Asia (Republic of Korea and Japan), Eastern Europe and Central and Latin America (1). The current meta-analysis included 13 reported from Asia and 7 reports from Europe. However, a worse prognosis with a high Ki-67 LI was observed in both Asia and Europe (HR = 1.260, 95% CI, and HR = 1.064, 95% CI, , respectively). Statistical significance was only identified in the European reports, but the pooled HR in the European reports was lower than that in the Asian reports. In addition, study location had no effect on heterogeneity in the meta-regression test. Although the Ki-67 LI is associated with tumor proliferation, the correlation with tumor progression in GC is unknown. Our meta-analysis is also the first one showing the correlations between a Ki-67 LI and clinicopathological characteristics, including depth of invasion, lymph node metastasis and ptnm stages. We showed the rates of high Ki-67 LI according to clinicopathological characteristics (Tab. II). However, there were no correlations between high Ki-67 LI and pt, pn or ptnm stages. We performed subgroup analysis for studies involving only AGC. There was no correlation between a high Ki-67 LI and poor prognosis in studies that included only AGC patients. Therefore, further studies are needed to verify the correlation between high Ki-67 LI and ptnm stages. The current meta-analysis had several limitations, in common with other meta-analyses. Publication bias is a possible bias in all meta-analyses. Although our meta-analysis included positive results as well as negative or noncorrelated results, this common bias cannot be discounted. However, Egger s and Begg s tests were performed for confirming publication bias, and no significant bias was found. A second limitation was that the studies included were performed in regions with a high incidence of GC. Therefore, it was difficult to determine the significance of study location in the current study. A lower incidence of GC might result in a lower publication rate due to less attention to GC. However, study location had no significant influence on heterogeneity in the meta-regression analysis. Thirdly, bias could also be caused by different evaluation methods in eligible studies in the current meta- analysis. The rate of high Ki- 67 LI was wide, ranging from 37.0% to 79.9%. We confirmed that dilution ratios, antibody manufacturers, immunohistochemical stain methods, cutoff values and evaluation protocols for Ki-67 LI were highly variable. These discrepancies might be responsible for the difficulty in determining a standard cutoff value in daily clinical practice. Furthermore, it makes it difficult to determine the prognostic role of Ki-67 LI. However, whether the variable results of eligible studies were caused by these discrepancies could not be determined in the current meta-analysis. Fourth, in AGC patients, a high Ki-67 LI did not predict the prognosis. However, an analysis for EGC patients could not be performed owing to insufficient information. Lastly, the comparison of the Ki-67 labeling index, according to Lauren s classification, could be important in understanding the distinct molecular and biological features. Tokuyasu et al reported that the Ki-67 LI of the intestinal type was significantly higher than that of the diffuse type (48.2 ± 14.6 vs ± 11.0, p<0.001) (26). However, the comparison between the intestinal and the diffuse types could not be performed in this meta-analysis owing to insufficient information within eligible studies. In conclusion, the present meta-analysis showed that a high Ki-67 LI correlated with a poor prognosis in GC and might be an important prognostic factor in GC. Further prospective studies for standardization of methods and for the Ki-67 LI evaluation system are needed to make them eligible for application in daily clinical practice. Acknowledgements The authors would like to thank Prof. Jin Hee Sohn of Kangbuk Samsung Hospital for her considered comments. Disclosures Financial support: This study is supported by Eulji Medi-Bio Research Institute (EMBRI) grants Conflict of interest: The authors declare that they have no conflict of interest. References 1. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4 th ed. Lyon, France: International Agency for Research on Cancer. 2010: Kim JY, Shin NR, Kim A, et al. Microsatellite instability status in gastric cancer: a reappraisal of its clinical significance and relationship with mucin phenotypes. Korean J Pathol. 2013;47(1): Edge SB, Byrd DR, Compton CC. The AJCC cancer staging manual. 7 th ed. New York: Springer. 2009: Gravalos C, Jimeno A. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol. 2008;19(9): Ishii HH, Gobe GC, Ebihara Y. p53 is an indicator of tumor progression in early but not advanced gastric carcinomas. Hepatogastroenterology. 2007;54(79): Kim JH, Kim MK, Lee HE, et al. Constitutive phosphorylation of the FOXO1A transcription factor as a prognostic variable in gastric cancer. Mod Pathol. 2007;20(8): Tsamandas AC, Kardamakis D, Tsiamalos P, et al. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67
7 Pyo and Kim e453 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome. Anticancer Res. 2009;29(2): Li T, Chen J, Liu QL, Huo ZH, Wang ZW. Meta-analysis: E-cadherin immunoexpression as a potential prognosis biomarker related to gastric cancer metastasis in Asian patients. Eur Rev Med Pharmacol Sci. 2014;18(18): Joo YE, Chung IJ, Park YK, et al. Expression of cyclooxygenase-2, p53 and Ki-67 in gastric cancer. J Korean Med Sci. 2006; 21(5): Mrena J, Wiksten JP, Kokkola A, Nordling S, Ristimäki A, Haglund C. COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer. Tumour Biol. 2010;31(1): Lieto E, Ferraraccio F, Orditura M, et al. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients. Ann Surg Oncol. 2008;15(1): Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182(3): Fukagawa T, Mikami Y, Nishihashi A, et al. CENP-H, a constitutive centromere component, is required for centromere targeting of CENP-C in vertebrate cells. EMBO J. 2001;20(16): Lowe K, Khithani A, Liu E, et al. Ki-67 labeling: a more sensitive indicator of malignant phenotype than mitotic count or tumor size? J Surg Oncol. 2012;106(6): Böger C, Behrens HM, Röcken C. Ki67: an unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity. J Surg Oncol. 2016;113(1): Chen L, Li X, Wang GL, Wang Y, Zhu YY, Zhu J. Clinicopathological significance of overexpression of TSPAN1, Ki67 and CD34 in gastric carcinoma. Tumori. 2008;94(4): Czyzewska J, Guzińska-Ustymowicz K, Pryczynicz A, Kemona A, Bandurski R. Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer. Folia Histochem Cytobiol. 2009;47(2): He WL, Li YH, Yang DJ, et al. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma. Eur J Surg Oncol. 2013;39(2): Ichinoe M, Mikami T, Yoshida T, et al. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions. Pathol Int. 2011;61(5): Lee HE, Kim MA, Lee BL, Kim WH. Low Ki-67 proliferation index is an indicator of poor prognosis in gastric cancer. J Surg Oncol. 2010;102(3): Lee SJ, Joo YE, Kim HS, et al. [Expression of cyclin dependent kinase inhibitors of KIP family in gastric cancer] [article in Korean]. Korean J Gastroenterol. 2005;46(2): Liu XP, Tsushimi K, Tsushimi M, et al. Expression of p21(waf1/ CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis. Cancer Lett. 2001; 170(2): Müller W, Schneiders A, Meier S, Hommel G, Gabbert HE. Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma. Br J Cancer. 1996;74(5): Shomori K, Nishihara K, Tamura T, et al. Geminin, Ki67, and minichromosome maintenance 2 in gastric hyperplastic polyps, adenomas, and intestinal-type carcinomas: pathobiological significance. Gastric Cancer. 2010;13(3): Sun Z, Zhu RJ, Yang GF, Li Y. Neoadjuvant chemotherapy with FOLFOX4 regimen to treat advanced gastric cancer improves survival without increasing adverse events: a retrospective cohort study from a Chinese center. Scientific World Journal. 2014;2014: Tokuyasu N, Shomori K, Nishihara K, et al. Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance. Gastric Cancer. 2008;11(1): Tzanakis NE, Peros G, Karakitsos P, et al. Prognostic significance of p53 and Ki67 proteins expression in Greek gastric cancer patients. Acta Chir Belg. 2009;109(5): Victorzon M, Roberts PJ, Haglund C, von Boguslawsky K, Nordling S. Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer. Anticancer Res. 1997;17(4B): Wen Y, Wang Q, Zhou C, et al. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery. Ann Surg Oncol. 2011;18(13): Wu A, Jia Y, Dong B, et al. Apoptosis and KI 67 index correlate with preoperative chemotherapy efficacy and better predict the survival of gastric cancer patients with combined therapy. Cancer Chemother Pharmacol. 2014;73(5): Xiao LJ, Zhao S, Zhao EH, et al. Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas. Oncol Lett. 2013;6(5): Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17(24): Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27(5): Liu LC, Xu WT, Wu X, Zhao P, Lv YL, Chen L. Overexpression of carbonic anhydrase II and Ki-67 proteins in prognosis of gastrointestinal stromal tumors. World J Gastroenterol. 2013; 19(16): Martin B, Paesmans M, Mascaux C, et al. Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. Br J Cancer. 2004;91(12): Pyo JS, Kang G, Sohn JH. Ki-67 labeling index can be used as a prognostic marker in gastrointestinal stromal tumor: a systematic review and meta-analysis. Int J Biol Markers. 2016;31(2):e204-e210.
Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer
Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors
More informationc-erbb-2 expression and prognosis of gastric cancer: a meta-analysis
c-erbb-2 expression and prognosis of gastric cancer: a meta-analysis Z.Q. Wang and B.J. Sun Department of Surgery, Affiliated Tongren Hospital, Shanghai Jiaotong University, Shanghai, China Corresponding
More informationValidation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer
Original Article Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Hee Suk Jung 1, Jin Gu Lee 2, Chang Young Lee 2, Dae Joon Kim 2, Kyung Young Chung 2 1 Department
More informationAssociation of mir-21 with esophageal cancer prognosis: a meta-analysis
Association of mir-21 with esophageal cancer prognosis: a meta-analysis S.-W. Wen 1, Y.-F. Zhang 1, Y. Li 1, Z.-X. Liu 2, H.-L. Lv 1, Z.-H. Li 1, Y.-Z. Xu 1, Y.-G. Zhu 1 and Z.-Q. Tian 1 1 Department of
More informationESD for EGC with undifferentiated histology
ESD for EGC with undifferentiated histology Jun Haeng Lee, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Biopsy: M/D adenocarcinoma ESD: SRC >>
More informationDisclosure of Relevant Financial Relationships
Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS
More informationAre there the specific prognostic factors for triplenegative subtype of early breast cancers (pt1-2n0m0)?
Are there the specific prognostic factors for triplenegative subtype of early breast cancers (pt1-2n0m0)? Department of General Surgery, Anam Hospital, Korea University, College of Medicine, 126-, Anam-dong
More informationA study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric cancer.
Biomedical Research 2018; 29 (2): 365-370 ISSN 0970-938X www.biomedres.info A study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric
More informationSatisfactory surgical outcome of T2 gastric cancer after modified D2 lymphadenectomy
Original Article Satisfactory surgical outcome of T2 gastric cancer after modified D2 lymphadenectomy Shupeng Zhang 1, Liangliang Wu 2, Xiaona Wang 2, Xuewei Ding 2, Han Liang 2 1 Department of General
More informationA systemic review and meta-analysis for prognostic values of pretreatment lymphocyte-to-monocyte ratio on gastric cancer
831094EJI0010.1177/2058739219831094European Journal of InflammationLi et al. letter2019 Letter to the Editor A systemic review and meta-analysis for prognostic values of pretreatment lymphocyte-to-monocyte
More informationCorrelation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients
1568 Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients LIYING GUO 1, YU ZHANG 2, WEI ZHANG 3 and DILIMINA YILAMU 1 1 Department of
More informationAnalysis of the outcome of young age tongue squamous cell carcinoma
Jeon et al. Maxillofacial Plastic and Reconstructive Surgery (2017) 39:41 DOI 10.1186/s40902-017-0139-8 Maxillofacial Plastic and Reconstructive Surgery RESEARCH Open Access Analysis of the outcome of
More informationOriginal Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical outcome
Int J Clin Exp Pathol 2017;10(2):2030-2035 www.ijcep.com /ISSN:1936-2625/IJCEP0009456 Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical
More informationRisk Factors and Tumor Recurrence in pt1n0m0 Gastric Cancer after Surgical Treatment
pissn : 293-582X, eissn : 293-5641 J Gastric Cancer 216;16(4):215-22 https://doi.org/1.523/jgc.216.16.4.215 Original Article Risk Factors and Tumor Recurrence in pt1nm Gastric Cancer after Surgical Treatment
More informationDisclosures. Outline. What IS tumor budding?? Tumor Budding in Colorectal Carcinoma: What, Why, and How. I have nothing to disclose
Tumor Budding in Colorectal Carcinoma: What, Why, and How Disclosures I have nothing to disclose Soo-Jin Cho, MD, PhD Assistant Professor UCSF Dept of Pathology Current Issues in Anatomic Pathology 2017
More informationInt J Biol Markers 2016; 31(2): e204-e210 DOI: /jbm
IJBM eissn 1724-6008 Int J Biol Markers 2016; 31(2): e204-e210 DOI: 10.5301/jbm.5000183 ORIGINAL RESEARCH ARTICLE Ki-67 labeling index can be used as a prognostic marker in gastrointestinal stromal tumor:
More informationPD-L1 over-expression and survival in patients with non-small cell lung cancer: a meta-analysis
Evidence-based Medicine PD-L1 over-expression and survival in patients with non-small cell lung cancer: a meta-analysis Ze-Jun Zhou, Ping Zhan, Yong Song Department of Respiratory Medicine, Jinling Hospital,
More informationCorrelation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer
Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer X.L. Liu 1, L.D. Liu 2, S.G. Zhang 1, S.D. Dai 3, W.Y. Li 1 and L. Zhang 1 1 Thoracic Surgery,
More informationStudy of expression of P53 in Gastric Carcinoma As a prognostic indicator
Original Research Article Study of expression of P53 in Gastric Carcinoma As a prognostic indicator K. Padma Malini 1*, Srivani 2, O. Shravan Kumar 3 1 Assistant Professor, 2 Associate Professor, 3 Professor
More informationClinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma
Original Article Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma Zhaode Bu, Zhixue Zheng, Ziyu Li, Xiaojiang Wu, Lianhai Zhang, Aiwen Wu,
More informationDoes the Retrieval of at Least 15 Lymph Nodes Confer an Improved Survival in Patients with Advanced Gastric Cancer?
J Gastric Cancer 2014;14(2):111-116 http://dx.doi.org/10.5230/jgc.2014.14.2.111 Original Article Does the Retrieval of at Least 15 Lymph Nodes Confer an Improved Survival in Patients with Advanced Gastric
More informationJun Lu, Chang-Ming Huang, Chao-Hui Zheng, Ping Li, Jian-Wei Xie, Jia-Bin Wang, and Jian-Xian Lin
Oncology Volume 22, Article ID 6428, 7 pages doi:.55/22/6428 Research Article Analysis on the Clinical and Pathological Features and Prognosis of Familial Gastric Cancer in South China Population: A Single-Center
More informationOriginal Article Lack of association between bcl-2 expression and prognosis of osteosarcoma: a meta-analysis
Int J Clin Exp Med 2015;8(6):9093-9099 www.ijcem.com /ISSN:1940-5901/IJCEM0008614 Original Article Lack of association between bcl-2 expression and prognosis of osteosarcoma: a meta-analysis Tao Fu 1*,
More informationOriginal Article Prognostic role of neuroendocrine cell differentiation in human gastric carcinoma
Int J Clin Exp Med 2015;8(5):7837-7842 www.ijcem.com /ISSN:1940-5901/IJCEM0003844 Original Article Prognostic role of neuroendocrine cell differentiation in human gastric carcinoma Tingting Zhang, Dan
More informationPerigastric lymph node metastases in gastric cancer: comparison of different staging systems
Gastric Cancer (1999) 2: 201 205 Original article 1999 by International and Japanese Gastric Cancer Associations Perigastric lymph node metastases in gastric cancer: comparison of different staging systems
More informationORIGINAL ARTICLE. International Journal of Surgery
International Journal of Surgery (2013) 11(S1), S90 S94 Contents lists available at ScienceDirect International Journal of Surgery journal homepage: www.journal-surgery.net ORIGINAL ARTICLE Lymph node
More informationReview Article Prognostic Role of MicroRNA-200c-141 Cluster in Various Human Solid Malignant Neoplasms
Disease Markers Volume 2015, Article ID 935626, 19 pages http://dx.doi.org/10.1155/2015/935626 Review Article Prognostic Role of MicroRNA-200c-141 Cluster in Various Human Solid Malignant Neoplasms Xiao-yang
More informationLog odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection
Original Article Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection Mingjian Yang 1,2, Hongdian Zhang 1,2, Zhao Ma 1,2, Lei Gong 1,2, Chuangui Chen
More informationCancer Cell Research 17 (2018)
Available at http:// www.cancercellresearch.org ISSN 2161-2609 Prognostic value of MicroRNA-21 in non-small cell lung cancer: a meta-analysis Fei Xu, Leina Ma, Lingxin Feng, Yinjie Wu, Xiaoyan Xu, Zhuang
More informationRatio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer
Original Article Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer Fangfang Chen 1 *, Yanwen Yao 2 *, Chunyan
More informationDetection and Clinical Significance of Lymph Node Micrometastasis in Gastric Cardia Adenocarcinoma
The Journal of International Medical Research 2012; 40: 293 299 [first published online ahead of print as 40(1) 3] Detection and Clinical Significance of Lymph Node Micrometastasis in Gastric Cardia Adenocarcinoma
More informationExpression of mir-1294 is downregulated and predicts a poor prognosis in gastric cancer
European Review for Medical and Pharmacological Sciences 2018; 22: 5525-5530 Expression of mir-1294 is downregulated and predicts a poor prognosis in gastric cancer Y.-X. SHI, B.-L. YE, B.-R. HU, X.-J.
More informationPrognostic Factors for Node-Negative Advanced Gastric Cancer after Curative Gastrectomy
pissn : 293-582X, eissn : 293-564 J Gastric Cancer 26;6(3):6-66 http://dx.doi.org/.523/jgc.26.6.3.6 Original Article Prognostic Factors for Node-Negative Advanced Gastric Cancer after Curative Gastrectomy
More informationLymph node ratio as a prognostic factor in stage III colon cancer
Lymph node ratio as a prognostic factor in stage III colon cancer Emad Sadaka, Alaa Maria and Mohamed El-Shebiney. Clinical Oncology department, Faculty of Medicine, Tanta University, Egypt alaamaria1@hotmail.com
More informationExosomal Del 1 as a potent diagnostic marker for breast cancer : A prospective cohort study
GBCC 2017: ABS-0017 Exosomal Del 1 as a potent diagnostic marker for breast cancer : A prospective cohort study Soo Jung Lee 1, Jeeyeon Lee 2, Jin Hyang Jung 2, Ho Yong Park 2, Chan Hyeong Lee 3, Pyong
More informationSupplementary Information
Supplementary Information Prognostic Impact of Signet Ring Cell Type in Node Negative Gastric Cancer Pengfei Kong1,4,Ruiyan Wu1,Chenlu Yang1,3,Jianjun Liu1,2,Shangxiang Chen1,2, Xuechao Liu1,2, Minting
More informationExpression of long non-coding RNA linc-itgb1 in breast cancer and its influence on prognosis and survival
European Review for Medical and Pharmacological Sciences 2017; 21: 3397-3401 Expression of long non-coding RNA linc-itgb1 in breast cancer and its influence on prognosis and survival W.-X. LI 1, R.-L.
More informationPrognostic Value of Plasma D-dimer in Patients with Resectable Esophageal Squamous Cell Carcinoma in China
1663 Ivyspring International Publisher Research Paper Journal of Cancer 2016; 7(12): 1663-1667. doi: 10.7150/jca.15216 Prognostic Value of Plasma D-dimer in Patients with Resectable Esophageal Squamous
More informationSmoking and Histological Factors Influencing Long-term Survival of Gastric Carcinoma in Consecutive Patient Series
Original Article Middle East Journal of Cancer 2014; 5(3): 127-133 Smoking and Histological Factors Influencing Long-term Survival of Gastric Carcinoma in Consecutive Patient Series Ali Delpisheh *, Yousef
More informationCharacteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases Mei Li & Zhi-xiong Lin Department of Radiation
More informationPeritoneal Involvement in Stage II Colon Cancer
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
More informationHigh expression of fibroblast activation protein is an adverse prognosticator in gastric cancer.
Biomedical Research 2017; 28 (18): 7779-7783 ISSN 0970-938X www.biomedres.info High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer. Hu Song 1, Qi-yu Liu 2, Zhi-wei
More informationThe Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC)
The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC) Disclosure None Background Torino, Italy LCNC Rare tumor (2% to 3% all resected primary lung cancers) Preoperative
More informationCancerous esophageal stenosis before treatment was significantly correlated to poor prognosis of patients with esophageal cancer: a meta-analysis
Original Article Cancerous before treatment was significantly correlated to poor prognosis of patients with cancer: a meta-analysis Han-Yu Deng 1,2#, Guha Alai 1#, Jun Luo 1#, Gang Li 1, Ze-Guo Zhuo 1,
More informationRadiotherapy and Conservative Surgery For Merkel Cell Carcinoma - The British Columbia Cancer Agency Experience
Radiotherapy and Conservative Surgery For Merkel Cell Carcinoma - The British Columbia Cancer Agency Experience Poster No.: RO-0003 Congress: RANZCR FRO 2012 Type: Scientific Exhibit Authors: C. Harrington,
More informationAdvances in gastric cancer: How to approach localised disease?
Advances in gastric cancer: How to approach localised disease? Andrés Cervantes Professor of Medicine Classical approach to localised gastric cancer Surgical resection Pathology assessment and estimation
More informationExpression of lncrna TCONS_ in hepatocellular carcinoma and its influence on prognosis and survival
European Review for Medical and Pharmacological Sciences 2017; 21: 5655-5660 Expression of lncrna TCONS_00027978 in hepatocellular carcinoma and its influence on prognosis and survival Q. CHEN 1, G.-D.
More informationExpression of SIRT1 and DBC1 in Gastric Adenocarcinoma
The Korean Journal of Pathology 2012; 46: 523-531 ORIGINAL ARTICLE Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma Youngran Kang Woon Yong Jung 1 Hyunjoo Lee 2 Eunjung Lee Aeree Kim Baek-hui Kim
More informationClinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05
Abstract No.: ABS-0075 Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer 2018/04/05 Cheol Min Kang Department of surgery, University of Ulsan
More informationPrognostic value of the 8 th tumor-node-metastasis classification for follicular carcinoma and poorly differentiated carcinoma of the thyroid in Japan
2018, 65 (6), 621-627 ORIGINAL Prognostic value of the 8 th tumor-node-metastasis classification for follicular carcinoma and poorly differentiated carcinoma of the thyroid in Japan Yasuhiro Ito 1), Akira
More informationThe detection rate of early gastric cancer has been increasing owing to advances in
Focused Issue of This Month Sung Hoon Noh, MD, ph.d Department of Surgery, Yonsei University College of Medicine E - mail : sunghoonn@yuhs.ac J Korean Med Assoc 2010; 53(4): 306-310 Abstract The detection
More informationIncidence and Multiplicities of Adenomatous Polyps in TNM Stage I Colorectal Cancer in Korea
Original Article Journal of the Korean Society of J Korean Soc Coloproctol 2012;28(4):213-218 http://dx.doi.org/10.3393/jksc.2012.28.4.213 pissn 2093-7822 eissn 2093-7830 Incidence and Multiplicities of
More informationTitle: Synuclein Gamma Predicts Poor Clinical Outcome in Colon Cancer with Normal Levels of Carcinoembryonic Antigen
Author's response to reviews Title: Synuclein Gamma Predicts Poor Clinical Outcome in Colon Cancer with Normal Levels of Carcinoembryonic Antigen Authors: Caiyun Liu (liucaiyun23@yahoo.com.cn) Bin Dong
More informationThe Expression of Tumor-Derived and Stromal-Derived Matrix Metalloproteinase 2 Predicted Prognosis of Ovarian Cancer
ORIGINAL STUDY The Expression of Tumor-Derived and Stromal-Derived Matrix Metalloproteinase 2 Predicted Prognosis of Ovarian Cancer Ziyi Fu, MD,* Sujuan Xu, MD,Þ Ye Xu, MD,Þ Jiehua Ma, MD,* Jingyun Li,
More informationImplications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers
日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu
More informationClinical Study The Expression of Bcl-2 and BID in Gastric Cancer Cells
Immunology Research, Article ID 953203, 5 pages http://dx.doi.org/10.1155/2014/953203 Clinical Study The Expression of Bcl-2 and BID in Gastric Cancer Cells Mariusz Gryko, 1 Anna Pryczynicz, 2 Konrad Zareba,
More informationPrognostic value of serum CYFRA 21-1 and CEA for non- small- cell lung cancer
Cancer Medicine ORIGINAL RESEARCH Open Access Prognostic value of serum CYFRA 21-1 and CEA for non- small- cell lung cancer Zhi-Hui Zhang 1,a, Yun-Wei Han 2,a, Hui Liang 3 & Le-Min Wang 4 1 Department
More informationTreatment Strategy for Non-curative Resection of Early Gastric Cancer. Jun Haneg Lee. Sungkyunkwan University, Samsung Medical Center, Seoul Korea
Treatment Strategy for Non-curative Resection of Early Gastric Cancer Jun Haneg Lee. Sungkyunkwan University, Samsung Medical Center, Seoul Korea Classic EMR/ESD data analysis style Endoscopic resection
More informationGenetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma
Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma M.J. Wang, Y. Zhu, X.J. Guo and Z.Z. Tian Department of Orthopaedics, Xinxiang Central Hospital, Xinxiang,
More informationWHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER?
CANCER STAGING TNM and prognosis in CRC WHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER? Alessandro Lugli, MD Institute of Pathology University of Bern Switzerland Maastricht, June 19
More informationA meta-analysis of clinical trials over regimens with or without cetuximab for advanced gastric cancer patients
JBUON 2017; 22(4): 900-904 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE A meta-analysis of clinical trials over regimens with or without cetuximab
More informationAlectinib Versus Crizotinib for Previously Untreated Alk-positive Advanced Non-small Cell Lung Cancer : A Meta-Analysis
Showa Univ J Med Sci 30 2, 309 315, June 2018 Original Alectinib Versus Crizotinib for Previously Untreated Alk-positive Advanced Non-small Cell Lung Cancer : A Meta-Analysis Ryo MANABE 1, Koichi ANDO
More informationAssociation between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis
Association between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis Y. Liu, H.L. Liu, W. Han, S.J. Yu and J. Zhang Department of Cardiology, The General Hospital of the
More informationGastrointestinal pathology 2018 lecture 4. Dr Heyam Awad FRCPath
Gastrointestinal pathology 2018 lecture 4 Dr Heyam Awad FRCPath Topics to be covered Peptic ulcer disease Hiatal hernia Gastric neoplasms Peptic ulcer disease (PUD)= chronic gastric ulcer Causes H pylori
More informationThe diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer
European Review for Medical and Pharmacological Sciences 2017; 21: 4039-4044 The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer H.-Y. FAN
More informationNumber of Metastatic Lymph Nodes in Resected Non Small Cell Lung Cancer Predicts Patient Survival
Number of Metastatic Lymph Nodes in Resected Non Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD, Dae Joon Kim, MD, Seong Yong Park, MD, Kil Dong Kim,
More informationReview Article Elevated expression of long noncoding RNA UCA1 can predict a poor prognosis: a meta-analysis
Int J Clin Exp Med 2016;9(6):9656-9664 www.ijcem.com /ISSN:1940-5901/IJCEM0025465 Review Article Elevated expression of long noncoding RNA UCA1 can predict a poor prognosis: a meta-analysis Tao Chen 1*,
More informationTitle: What is the role of pre-operative PET/PET-CT in the management of patients with
Title: What is the role of pre-operative PET/PET-CT in the management of patients with potentially resectable colorectal cancer liver metastasis? Pablo E. Serrano, Julian F. Daza, Natalie M. Solis June
More informationLow levels of serum mir-99a is a predictor of poor prognosis in breast cancer
Low levels of serum mir-99a is a predictor of poor prognosis in breast cancer J. Li 1, Z.J. Song 2, Y.Y. Wang 1, Y. Yin 1, Y. Liu 1 and X. Nan 1 1 Tumor Research Department, Shaanxi Provincial Tumor Hospital,
More informationCurrent status of gastric ESD in Korea. Jun Haeng Lee. Department of Medicine Sungkyunkwanuniversity School of Medicie, Seoul, Korea
Current status of gastric ESD in Korea Jun Haeng Lee. Department of Medicine Sungkyunkwanuniversity School of Medicie, Seoul, Korea Contents Brief history of gastric ESD in Korea ESD/EMR for gastric adenoma
More informationPrognostic factors in curatively resected pathological stage I lung adenocarcinoma
Original Article Prognostic factors in curatively resected pathological stage I lung adenocarcinoma Yikun Yang 1, Yousheng Mao 1, Lin Yang 2, Jie He 1, Shugeng Gao 1, Juwei Mu 1, Qi Xue 1, Dali Wang 1,
More informationClinical Features and Survival Analysis of T1mic, a, bn0m0 Breast Cancer
Original Articles Jpn J Clin Oncol 2012;42(6)471 476 doi:10.1093/jjco/hys046 Advance Access Publication 3 April 2012 Clinical Features and Survival Analysis of T1mic, a, bn0m0 Breast Cancer Junnan Li,
More informationOriginal Article Tissue expression level of lncrna UCA1 is a prognostic biomarker for colorectal cancer
Int J Clin Exp Pathol 2016;9(4):4241-4246 www.ijcep.com /ISSN:1936-2625/IJCEP0012296 Original Article Tissue expression level of lncrna UCA1 is a prognostic biomarker for colorectal cancer Hong Jiang,
More informationThe Expression of Beclin-1 in Hepatocellular Carcinoma and Non-Tumor Liver Tissue: A Meta-Analysis
The Expression of Beclin-1 in Hepatocellular Carcinoma and Non-Tumor Liver Tissue: A Meta-Analysis Zhiqiang Qin¹, Xinjuan Yu², Jinkun Wu¹, Mei Lin¹ 1 Department of Pathology, School of Basic Medicine,
More informationMismatch repair status, inflammation and outcome in patients with primary operable colorectal cancer
Mismatch repair status, inflammation and outcome in patients with primary operable colorectal cancer Park JH, Powell AG, Roxburgh CSD, Richards CH, Horgan PG, McMillan DC, Edwards J James Park Clinical
More informationORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery
Nagoya J. Med. Sci. 79. 37 ~ 42, 2017 doi:10.18999/nagjms.79.1.37 ORIGINAL PAPER Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Naoki Ozeki, Koji
More informationClaudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression
Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression Mona A. Abd-Elazeem, Marwa A. Abd- Elazeem Pathology department, Faculty of Medicine, Tanta
More informationCancer Cell Research 14 (2017)
Available at http:// www.cancercellresearch.org ISSN 2161-2609 Efficacy and safety of bevacizumab for patients with advanced non-small cell lung cancer Ping Xu, Hongmei Li*, Xiaoyan Zhang Department of
More informationSignificance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma
ORIGINAL STUDY Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma Jeong-Yeol Park, MD, PhD, Dae-Yeon Kim, MD, PhD, Dae-Shik Suh, MD, PhD, Jong-Hyeok Kim, MD, PhD, Yong-Man
More informationReview Article Long Noncoding RNA H19 in Digestive System Cancers: A Meta-Analysis of Its Association with Pathological Features
BioMed Research International Volume 2016, Article ID 4863609, 8 pages http://dx.doi.org/10.1155/2016/4863609 Review Article Long Noncoding RNA H19 in Digestive System Cancers: A Meta-Analysis of Its Association
More informationRESEARCH ARTICLE. Fatih Selcukbiricik 1 *, Sibel Erdamar 2, Evin Buyukunal 3, Suheyla Serrdengecti 3, Fuat Demirelli 3. Abstract.
DOI:http://dx.doi.org/10.731/APJCP.201.15.2.10607 RESEARCH ARTICLE Is Her-2 Status in the Primary Tumor Correlated with Matched Lymph Node Metastases in Patients with Gastric Cancer Undergoing Curative
More informationAnalysis of Lymph Node Metastasis Correlation with Prognosis in Patients with T2 Gastric Cancer
Analysis of Lymph Node Metastasis Correlation with Prognosis in Patients with T2 Gastric Cancer Xiaowen Liu 1,2, Ziwen Long 1,2, Hong Cai 1,2, Hua Huang 1,2, Yingqiang Shi 1,2, Yanong Wang 1,2 * 1 Department
More informationSurvival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Survival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China Yu-Tao Liu, Xue-Zhi Hao, Jun-Ling Li, Xing-Sheng
More informationCancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006
Chinese Journal of Cancer Original Article Cancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006 Xiao-Pan Li 1, Guang-Wen Cao 2, Qiao
More informationClinical and prognostic significance of HIF- 1α overexpression in oral squamous cell carcinoma: a meta-analysis
Zhou et al. World Journal of Surgical Oncology (2017) 15:104 DOI 10.1186/s12957-017-1163-y RESEARCH Open Access Clinical and prognostic significance of HIF- 1α overexpression in oral squamous cell carcinoma:
More informationGlasgow Prognostic Score (GPS) Can Be a Useful Indicator to Determine Prognosis of Patients With Colorectal Carcinoma
Int Surg 2014;99:512 517 DOI: 10.9738/INTSURG-D-13-00118.1 Glasgow Prognostic Score (GPS) Can Be a Useful Indicator to Determine Prognosis of Patients With Colorectal Carcinoma Tadahiro Nozoe, Rumi Matono,
More informationDiagnostic and prognostic value of CEA, CA19 9, AFP and CA125 for early gastric cancer
Feng et al. BMC Cancer (2017) 17:737 DOI 10.1186/s12885-017-3738-y RESEARCH ARTICLE Open Access Diagnostic and prognostic value of CEA, CA19 9, AFP and CA125 for early gastric cancer Fan Feng 1, Yangzi
More informationSCIENCE CHINA Life Sciences
SCIENCE CHINA Life Sciences RESEARCH PAPER April 2013 Vol.56 No.4: 335 340 doi: 10.1007/s11427-013-4435-y Risk factors of recurrence in small-sized, node negative breast cancer in young women: a retrospective
More informationThe effect of delayed adjuvant chemotherapy on relapse of triplenegative
Original Article The effect of delayed adjuvant chemotherapy on relapse of triplenegative breast cancer Shuang Li 1#, Ding Ma 2#, Hao-Hong Shi 3#, Ke-Da Yu 2, Qiang Zhang 1 1 Department of Breast Surgery,
More informationTreatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy
Korean J Hepatobiliary Pancreat Surg 2011;15:152-156 Original Article Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Suzy Kim 1,#, Kyubo
More informationChibueze Onyemkpa 1, Alan Davis 1, Michael McLeod 1, Tolutope Oyasiji 1,2. Original Article
Original Article Typical carcinoids, goblet cell carcinoids, mixed adenoneuroendocrine carcinomas, neuroendocrine carcinomas and adenocarcinomas of the appendix: a comparative analysis of survival profile
More informationSystematic reviews and meta-analyses of observational studies (MOOSE): Checklist.
Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:
More informationLocoregional treatment Session Oral Abstract Presentation Saulo Brito Silva
Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer
More informationLower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance
Original Article Lower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance Dedrick Kok Hong Chan 1,2, Ker-Kan Tan 1,2 1 Division of Colorectal Surgery, University
More informationDownregulation of long non-coding RNA LINC01133 is predictive of poor prognosis in colorectal cancer patients
European Review for Medical and Pharmacological Sciences 2017; 21: 2103-2107 Downregulation of long non-coding RNA LINC01133 is predictive of poor prognosis in colorectal cancer patients J.-H. ZHANG 1,
More informationExtended multi-organ resection for ct4 gastric carcinoma: A retrospective analysis
Original Article Extended multi-organ resection for ct4 gastric carcinoma: A retrospective analysis 1. Longbin Xiao, 2. Mingzhe Li, 3. Fengfeng Xu, Department of General Surgery I, 4. Huishao Ye, Department
More informationClinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients
Yonago Acta medica 2012;55:57 61 Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients Hiroaki Saito, Seigo Takaya, Yoji Fukumoto, Tomohiro Osaki, Shigeru Tatebe and Masahide
More informationCase Report Intramucosal Signet Ring Cell Gastric Cancer Diagnosed 15 Months after the Initial Endoscopic Examination
Hindawi Publishing Corporation Case Reports in Medicine Volume 2015, Article ID 479625, 5 pages http://dx.doi.org/10.1155/2015/479625 Case Report Intramucosal Signet Ring Cell Gastric Cancer Diagnosed
More informationEvaluation the Correlation between Ki67 and 5 Years Disease Free Survival of Breast Cancer Patients
BIOSCIENCES BIOTECHNOLOGY RESEARCH ASIA, December 2015. Vol. 12(3), 2221-2225 Evaluation the Correlation between Ki67 and 5 Years Disease Free Survival of Breast Cancer Patients S.M. Hosseini¹, H. Shahbaziyan
More informationCD133 Protein Expression as a Biomarker for Early Detection of Gastric Cancer.
CD133 Protein Expression as a Biomarker for Early Detection of Gastric Cancer. Sameer Al Diffalha, MD Domenico Coppola, MD February 3rd 2017 Introduction of Gastric Cancers (GC) 4th most common cancer
More information